Expert suggests using a risk pyramid to classify medical devices under the EU AI Act for conformity assessments. High-risk devices need assessments; low-risk items face transparency obligations, while minimal-risk devices are unregulated. Compliance involves documentation, labeling, and risk management. AI tools will advance diagnostics, exemplified by non-invasive tests like LiverMultiScan.
